• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

  • View
  • Track
TypePostAuthorRepliesLast updated
Blog entryThe SFA School of Thought Continues Lawrence A. Gar...06 weeks 3 days ago
Blog entryEvaluating the SFA Conundrum Lawrence A. Gar...017 weeks 3 days ago
Blog entryA Review Of Drug-Eluting Technologies in SFA Lawrence A. Gar...019 weeks 3 days ago
Blog entryThe Truly Untested Modality: Drug Elution Lawrence A. Gar...023 weeks 3 days ago
Blog entryShedding Light with Single-Center Case Studies Lawrence A. Gar...127 weeks 1 day ago
Blog entryHead-to-Head Trial Needed to Answer Long SFA Lesion Question Lawrence A. Gar...131 weeks 4 days ago
Blog entrySFA Data Boosted from Zilver Trial at SCAI Meeting Lawrence A. Gar...031 weeks 4 days ago
Blog entrySlow Road to Clear Data on SFA Interventions Lawrence A. Gar...133 weeks 21 hours ago
Blog entryOptimal Balloon Angioplasty vs. Stenting for SFA Lesions Up to 20 cm Lawrence A. Gar...01 year 4 weeks ago
Blog entrySFA Data Becoming Somewhat Clearer Lawrence A. Gar...01 year 12 weeks ago
Blog entryDrug Elution in the SFA: Let's See Where This Goes Lawrence A. Gar...01 year 17 weeks ago
Blog entryCan Real-World Data Be Obtained for Lower-Extremity Revascularization? Lawrence A. Gar...01 year 25 weeks ago
Blog entryWhere Will the SFA Data Ultimately Lead? Lawrence A. Gar...11 year 29 weeks ago
Blog entryThe SFA Conundrum Continued Lawrence A. Gar...01 year 35 weeks ago
Blog entryMore on the SFA Data Discussion Lawrence A. Gar...01 year 39 weeks ago
Blog entryA New Vascular Disease Sounding Board Lawrence A. Gar...11 year 40 weeks ago
Blog entryMore on Evidence-Based Medicine for Lower Extremity Revascularization Lawrence A. Gar...01 year 42 weeks ago
Blog entrySFA Revascularization Lawrence A. Gar...01 year 48 weeks ago
Blog entryWhere Are the SFA Data? Lawrence A. Gar...01 year 48 weeks ago

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Alex Dulnikowski, Classified Sales Manager
    (800) 237-7285, ext. 205

vdm Blogs

A New Algorithm to Treat Patients with Peripheral Vascular Disease

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT

In-Stent Restenosis in the SFA Remains a Significant Unresolved Problem

Frank J Criado MD FACS FSVM

Support Comes From Many Directions

Richard R. Heuser MD FACC FACP FESC FSCAI

Pedal Artery Access: Advances in Management of Critical limb ischemia

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT

The SFA School of Thought Continues

Lawrence A. Garcia MD
more »

Vascular Newswire

  • Vascular Solutions Launches Reprocessing Service For Closurefast Vein Catheters
    Fri, 02/03/12 - 1:14pm
  • AMA: Halt Implementation of ICD-10
    Thu, 02/02/12 - 11:56am
  • NHS Makes GBP200 Non-Drug Hypertension Treatment Device Available on Prescription
    Wed, 02/01/12 - 11:06am
  • AngioDynamics to Acquire Navilyst Medical
    Tue, 01/31/12 - 2:48pm
more »

Clinical Events Calendar

  • American Venous Forum 24th Annual Meeting
    Wed, 02/08/2012 - Sat, 02/11/2012
    Orlando, FL, United States
  • JIM 2012
    Thu, 02/09/2012 - Sat, 02/11/2012
    Rome, Italy
  • Cardiovascular Care Update 2012 (CVC)
    Fri, 02/10/2012 - Sat, 02/11/2012
    Scottsdale, AZ, United States
more »

Poll

Do you think that endostaples will soon become important tools in the hands of aortic interventionists?:
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications